807 / 1851
ESMO PRECEPTORSHIP PROGRAM
Study
Stage
I/II/III-IV
%
2 Year
LocRegional
Failure Rate
2 Year
Overall
Survival
RTOG 9811
control:
MMC + 5-FU
47/19/31
25 %
91%
RTOG 9811*:
5-FU + Cis
48/17/31
28 %
85%
ECOG 3205
11/50/39
13%
93 %
AMC 045
24/42/34
7%
89 %